Home > Companies > Primary Health Care, Inc (PHC)

Primary Health Care, Inc (PHC)

PHC is a nonprofit community health center dedicated to serving the medically insured, uninsured and underinsured with their health care needs. With nine clinics in central Iowa, our providers strive to find and successfully treat medical conditions before they become serious enough to require hospitalization or emergency treatment. PHC also provides follow-up, continuity of care, pharmacy assistance, and supportive services to help patients in need. Through case management and social work advocacy, our staff works to ensure that our clients have greater access to resources in the community.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

Cell and Gene Therapy Global Congress 2022

Conference

Arrhythmias and metabolic pathways/ new mechanisms, new opportunities

Webinar

AlgaEurope 2022

Conference

Round Table discussion - Role of Risk Stratification for Cardio Vascular Disease in the COVID-19 era and its economic benefits

Webinar

BIOPOLYMER Processing & Moulding Congress 2022

Webinar

International Conference on Quantitative Genetics and Genomics

Conference

Related News

INDUSTRIAL IMPACT

BEIGENE ANNOUNCES LAUNCH OF BIOISLAND INNOVATION CENTER

BeiGene | December 27, 2021

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines, announced the official launch of the BeiGene Bioisland Innovation Center in Guangzhou, China to enable scientists and entrepreneurs to accelerate development of highly differentiated, cutting-edge medical innovations. The BIC is an innovator-centric incubator built on BeiGene’s goal of supporting exploration of new paths to meet patient needs around the world. Read More

RESEARCH

SYNTHACE UNVEILS FIRST LIFE SCIENCES R&D CLOUD ADDRESSING COMPLEXITY, SPEED & REPRODUCIBILITY FOR SCIENTISTS

Synthace | August 03, 2021

Synthace, a leading life sciences software company, today announced the first life sciences R&D cloud that includes a no-code software platform addressing the largest barriers to innovation that R&D life scientists currently face. With the release of this new platform, Synthace is also the first vendor to enable scientists to automate experimentation and insight sharing in a unified, global R&D environment. Scientists can now focus on asking the most impactful questions and unlock th...

BIOCARE MEDICAL AND BETHYL LABORATORIES ANNOUNCES THE RELEASE OF A NEW RABBIT MONOCLONAL ANTIBODY FOR IMMUNOHISTOCHEMICAL APPLICATIONS

Biocare Medical | August 05, 2020

Biocare Medical LLC, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, in collaboration with Bethyl Laboratories announces the release of a new rabbit monoclonal antibody, TIGIT [BLR047F] antibody for in vitro diagnostic (IVD) use in the qualitative identification of the TIGIT protein by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues.TIGIT plays an important role in transplantation tolerance and tumor i...

INDUSTRIAL IMPACT

OMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCESOMASS THERAPEUTICS TO PRESENT AT UPCOMING CONFERENCES

OMass Therapeutics | February 21, 2022

OMass Therapeutics a biotechnology company identifying medicines against highly validated target ecosystems, is pleased to confirm that it will be presenting at a number of upcoming banking, business and scientific conferences, as detailed below. “As we develop our unique drug discovery platform, OdyssION™, and progress our pipeline of small molecule therapeutics in rare diseases and immunological conditions, targeting solute carriers, complex-bou...

INDUSTRIAL IMPACT